Will triclosan in toothpase select for resistant oral streptococci?

Clinical Microbiology and Infection

Volumn 9, Issue 4, 2003, Pages 306-309

  Sullivan, A ^a   Wretlind, B ^a   Nord, Carl Erik ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; PENICILLIN G; TETRACYCLINE; TOOTHPASTE; TRICLOSAN; TOPICAL ANTIINFECTIVE AGENT;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; LONG TERM CARE; MINIMUM INHIBITORY CONCENTRATION; MOUTH FLORA; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SALIVA ANALYSIS; AEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; CLASSIFICATION; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOUTH HYGIENE; SALIVA; STREPTOCOCCUS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS SANGUINIS;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS;

ANTI-INFECTIVE AGENTS, LOCAL; BACTERIA, AEROBIC; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; ORAL HYGIENE; SALIVA; STREPTOCOCCUS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS SANGUIS; TOOTHPASTE; TRICLOSAN;

EID: 0038071568     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2003.00486.x     Document Type: Article

References (16)

1. Eley BM. Antibacterial agents in the control of supragingival plaque - a review. Br Dent J 1999; 186: 286-96.
2. Mustafa M, Wondimu B, Ibrahim M, Modéer T. Effect of triclosan on interleukin-1β production in human gingival fibroblasts challenged with tumor necrosis factor α. Eur J Oral Sci 1998; 106: 637-43.
3. Saunders KA, Greenman J, McKenzie C. Ecological effects of triclosan and triclosan monophosphate on defined mixed cultures of oral species grown in continuous culture. J Antimicrob Chemother 2000; 45: 447-52.
4. McMurry LM, Oethinger M, Levy SB. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol Lett 1998; 166: 305-9.
5. Suller MTE, Russell AD. Antibiotic and biocide resistance in methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus. J Hosp Infect 1999; 43: 281-91.
6. Chuanchuen R, Beinlich K, Hoang TT, Becher A, Karkhoff-Schweizer RR, Schweizer HP. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob Agents Chemother 2001; 45: 428-32.
7. Kennedy HF, Smith AJ. Viridans streptococcal infection in the medically compromised. Rev Med Microbiol 2000; 11: 77-86.
8. Marron A, Carratalà J, Alcaide F, Fernández-Sevilla A, Gudiol F. High rates of resistance to cephalosporins among viridans-group streptococci causing bacteraemia in neutropenic cancer patients. J Antimicrob Chemother 2001; 47: 87-91.
9. Graber CJ, de Almeida KNF, Atkinson JC et al. Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2001; 27: 537-42.
10. Diekema DJ, Beach ML, Pfaller MA, Jones RN, and the SENTRY Participants Group. Antimicrobial resistance in viridans streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America. Clin Microbiol Infect 2001; 7: 152-7.
11. Fluit AC, Jones EJ, Schmitz FJ et al. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. Clin Infect Dis 2000; 30: 454-60.
12. Lund B, Edlund C, Rynnel-Dagöö B, Lundgren Y, Sterner J, Nord CE. Ecological effects on the oro- and nasopharyngeal microflora in children after treatment of acute otitis media with cefuroxime axetil or amoxycillin-clavulanate as suspensions. Clin Microbiol Infect 2001; 6: 230-7.
13. Rodloff AC, Hillier SL, Moncla BJ. Peptostreptococcus, propionibacterium, lactobacillus, actinomyces, and other non-spore-forming anaerobic gram-positive bacteria. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology, 7th edn. Washington, DC: ASM Press, 1999: 672-89.
14. Jousimies-Somer HR, Summanen PH, Finegold SM. Bacteroides, porprhyromonas, prevotella, fusobacterium, and other anaerobic gram-negative rods and cocci. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology, 7th edn. Washington, DC: ASM Press, 1999: 690-711.
15. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5. Villanova, PA: NCCLS, 2000.
16. National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard M11-A5. Villanova, PA: NCCLS, 2001.